Down-regulation of Bcl-2, Bcl-xL, and survivin and up-regulation of the expression of Bax, Bak, PUMA, Noxa, and Bim, and DR4/5 in prostate cancer PC-3 and DU-145 cells. This evidence concerns the gene BCL2L11 and Familial prostate cancer.